NO972278L - Fluorerte vitamin D3-analoger - Google Patents

Fluorerte vitamin D3-analoger

Info

Publication number
NO972278L
NO972278L NO972278A NO972278A NO972278L NO 972278 L NO972278 L NO 972278L NO 972278 A NO972278 A NO 972278A NO 972278 A NO972278 A NO 972278A NO 972278 L NO972278 L NO 972278L
Authority
NO
Norway
Prior art keywords
double bond
hydrogen
bond
alkyl
independently
Prior art date
Application number
NO972278A
Other languages
English (en)
Norwegian (no)
Other versions
NO972278D0 (no
Inventor
Percy Sarwood Manchand
Jr John Joseph Nestor
Milan Radoje Uskokovic
Brian Henry Vickery
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO972278D0 publication Critical patent/NO972278D0/no
Publication of NO972278L publication Critical patent/NO972278L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO972278A 1996-05-23 1997-05-20 Fluorerte vitamin D3-analoger NO972278L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1821996P 1996-05-23 1996-05-23
US3990197P 1997-03-19 1997-03-19

Publications (2)

Publication Number Publication Date
NO972278D0 NO972278D0 (no) 1997-05-20
NO972278L true NO972278L (no) 1997-11-24

Family

ID=26690870

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972278A NO972278L (no) 1996-05-23 1997-05-20 Fluorerte vitamin D3-analoger

Country Status (26)

Country Link
EP (1) EP0808832B1 (fr)
JP (1) JP2859248B2 (fr)
KR (1) KR100253961B1 (fr)
CN (1) CN100402497C (fr)
AR (1) AR007776A1 (fr)
AT (1) ATE238278T1 (fr)
AU (1) AU733970B2 (fr)
BR (1) BR9703385A (fr)
CA (1) CA2205315C (fr)
CO (1) CO4940503A1 (fr)
CZ (1) CZ157797A3 (fr)
DE (1) DE69721123T2 (fr)
DK (1) DK0808832T3 (fr)
ES (1) ES2195049T3 (fr)
HR (1) HRP970272A2 (fr)
HU (1) HUP9700928A3 (fr)
IL (1) IL120844A0 (fr)
MA (1) MA24250A1 (fr)
NO (1) NO972278L (fr)
NZ (1) NZ314840A (fr)
PE (1) PE66798A1 (fr)
PL (1) PL320130A1 (fr)
PT (1) PT808832E (fr)
SG (1) SG70010A1 (fr)
TR (1) TR199700416A2 (fr)
YU (1) YU20097A (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008209A (en) * 1997-04-28 1999-12-28 Hoffmann-La Roche Inc. Method of using vitamin D3 analogs with bis C-20 side chains
DE19935771A1 (de) 1999-07-23 2001-02-01 Schering Ag Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
AU2001278744A1 (en) * 2000-08-17 2002-02-25 Chugai Seiyaku Kabushiki Kaisha Remedial agent for osteoporosis
JP2005503434A (ja) * 2001-09-21 2005-02-03 エフ.ホフマン−ラ ロシュ アーゲー 3−デスオキシ−ビタミンd3類似体
AU2004203436A1 (en) 2003-09-24 2005-04-14 Bioxell Spa Compound and use in treatment
CN101106985A (zh) * 2004-09-24 2008-01-16 拜奥艾克塞尔股份公司 20-环烷基,26,27-烷基/卤代烷基维生素d3化合物及其使用方法
WO2006102647A1 (fr) * 2005-03-23 2006-09-28 Bioxell S.P.A. Vitamine d3 gemini 20-alkyle, composes et procedes d’utilisation
PL2634171T3 (pl) * 2010-10-25 2015-12-31 Teijin Ltd 23-ynowa pochodna witaminy D3

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4141746A1 (de) * 1991-12-13 1993-06-17 Schering Ag 20-methyl-substituierte vitamin d-derivate
DE4220757A1 (de) * 1992-06-24 1994-01-05 Schering Ag Derivate in der Vitamin D-Reihe mit Modifikationen in der 20-Position, Verfahren zu ihrer Herstellung, Zwischenprodukte für dieses Verfahren, diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US5384314B1 (en) * 1994-03-11 1997-08-05 Hoffmann La Roche 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol
AU7295696A (en) * 1995-10-27 1997-05-22 F. Hoffmann-La Roche Ag Pharmaceutical composition for treating osteoporosis

Also Published As

Publication number Publication date
CA2205315C (fr) 2006-10-24
IL120844A0 (en) 1997-09-30
PL320130A1 (en) 1997-11-24
EP0808832A3 (fr) 1999-02-03
KR970074764A (ko) 1997-12-10
PT808832E (pt) 2003-07-31
HRP970272A2 (en) 1998-04-30
JPH1045714A (ja) 1998-02-17
DE69721123T2 (de) 2004-01-08
DK0808832T3 (da) 2003-08-11
DE69721123D1 (de) 2003-05-28
KR100253961B1 (ko) 2000-04-15
TR199700416A2 (xx) 1997-12-21
ES2195049T3 (es) 2003-12-01
CN100402497C (zh) 2008-07-16
JP2859248B2 (ja) 1999-02-17
AU733970B2 (en) 2001-05-31
CA2205315A1 (fr) 1997-11-23
CN1172801A (zh) 1998-02-11
CO4940503A1 (es) 2000-07-24
HUP9700928A3 (en) 1999-07-28
CZ157797A3 (en) 1997-12-17
MX9703775A (es) 1998-06-30
HUP9700928A2 (hu) 1998-01-28
BR9703385A (pt) 1998-09-15
YU20097A (sh) 1999-09-27
AU2357697A (en) 1997-11-27
NZ314840A (en) 1998-11-25
AR007776A1 (es) 1999-11-24
EP0808832B1 (fr) 2003-04-23
NO972278D0 (no) 1997-05-20
PE66798A1 (es) 1998-10-22
HU9700928D0 (en) 1997-07-28
MA24250A1 (fr) 1998-04-01
SG70010A1 (en) 2000-01-25
EP0808832A2 (fr) 1997-11-26
ATE238278T1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
HU9401950D0 (en) New aryl- and heteroaryl-ethylene derivatives and process for producing them
DE69208078D1 (de) Fluorierte kohlenwasserstoffderivate, ihre verwendung in kosmetischen zusammensetzungen, verfahren zu ihrer herstellung und sie enthaltende kosmetische zusammensetzungen
DK0707472T3 (da) Fremgangsmåde til regulering af størrelsen af liposomer
NO972278L (no) Fluorerte vitamin D3-analoger
ID18576A (id) Senyawa antara untuk membuat turunan-turunan steroid yang digunakan dalam pengobatan hipertropi prostatik dan pembuatannya
DE3762615D1 (de) Verfahren zur herstellung von (2,2)-paracyclophan und dessen derivaten.
GB2283016A (en) Scavenging of hydrogen sulphide
IL83141A (en) Solutions of oxazophosphorins having improved stability and their preparation
ES8601843A1 (es) Procedimiento para el tratamiento de textiles
AU6559994A (en) Stable moulding or spinning compound containing cellulose
GB1477293A (en) Tetralone and indanone derivatives and process for their preparations
AU1706495A (en) Stabilizer mixture made up of chromane derivatives, organic phosphites or phosphonites and amines
EA199800468A1 (ru) 25-гидрокси-16-ен-26,27-бисгомохолекальциферолы
HU9502179D0 (en) Piperazine derivatives for producing alkyl-trazodon derivatives and process for producing them
AU683148B2 (en) Cyclohexane derivatives, process for their preparation, and the use of the compounds for the treatment of diseases
JPS5735506A (en) Bleaching cosmetic
NO940113L (no) Syntese av 2-fenyl-substituerte 1,3-propandioler
FI832007A0 (fi) En ny mikroorganismstam chromobacterium violaceum, medelst denna stam framstaellda farmaceutiskt aktiva foereningar, ett foerfarande foer framstaellning av foereningarna och anvaendning av dessa foereningar som laekemedel
JPS5745169A (en) Benzotriazole compound and its preparation
ES2150564T3 (es) Proceso para la preparacion de derivados de 5,6-dihidroxi-2-amino-1,2,3,4-tetrahidronaftaleno.
SU1837613A1 (ru) Гидрофобизатор для обработки бетона
US4268669A (en) 9-Deoxy-9-methylene-5,6-didehydro-PGF1 amides
JPS56152827A (en) Stabilized polyurethane
MX9603450A (es) Procedimiento para la obtencion de aminotriazolinas substituidas.
UA18619A (uk) Спосіб одержаhhя сірки